Proceedings of the National Academy of Sciences · 1992 · 154 citations · 23 references
Life SciencesNeurosciencePharmacologyMolecular NeuroscienceNeurochemistryNeuropharmacologyCalcium SignalingCentral Nervous System ToxicityIntracellular Calcium SignalingNeuroprotectionNeurotoxic MechanismsNeurotoxicity MechanismsCa2+ SignalingCalcium Release From Intracellular StoresCalcium Signaling In NeuronsDantrolene TherapyGlutamate-induced NeurotoxicityIntracellular Calcium DynamicsN-methyl-d-aspartate Receptor-mediated ExcitotoxicityNeuronal Calcium Handling
By using primary cultures of cerebral cortical neurons, it has been demonstrated that the antihyperthermia drug dantrolene protects against cytotoxicity induced by the excitatory amino acids quisqualate (QA) and N-methyl-D-aspartate (NMDA), whereas no effect was observed on cell damage mediated by kainate (KA) or 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionate (AMPA). In parallel it was shown that KA and AMPA increased the concentration of intracellular free calcium ([Ca2+]i) mainly by influx, whereas the increase in [Ca2+]i stimulated by NMDA and QA predominantly was caused by release of Ca2+ from intracellular stores, which for NMDA seemed to be mediated at least partly by Ca2+ influx. In accordance with the effects on cytotoxicity, dantrolene blocked the increase in [Ca2+]i elicited by QA and NMDA leaving the increase induced by KA and AMPA unaffected. The finding that 2-amino-3-[3-(carboxymethoxy)-5-methylisoxazol-4-yl]propionate, which regarding toxicity is a selective KA antagonist, only reduced the KA-stimulated increase in [Ca2+]i by 30% may suggest that the elevation of [Ca2+]i is not the only element in KA-induced cytotoxicity. On the other hand, the present study underlines the importance of Ca2+ for cytotoxicity induced by some excitatory amino acids (glutamate, NMDA, and QA) and supports the current proposal that multiple mechanisms are operating, even concerning calcium homeostasis. Because excitatory amino acid-induced cytotoxicity is thought to be involved in neuropathological conditions such as ischemia, it is possible that dantrolene might be of therapeutic interest.
23
Glutamate neurotoxicity and diseases of the nervous system
Dennis W. Choi · Neuron · 1988 · 8K citations
Quinoxalinediones: Potent Competitive Non-NMDA Glutamate Receptor Antagonists
Tage Honoré, S.N. Davies, Jørgen Drejer et al. · Science · 1988 · 1.2K citations
Glutamate stimulates inositol phosphate formation in striatal neurones
Fritz Sladeczek, Jean‐Philippe Pin, Max Récasens et al. · Nature · 1985 · 747 citations